Cargando…
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16(INK4a)
BACKGROUND: Although chemotherapy saves lives, increasing evidence shows that chemotherapy accelerates aging. We previously demonstrated that mRNA expression of p16(INK4a), a biomarker of senescence and molecular aging, increased early and dramatically after beginning adjuvant anthracycline-based re...
Autores principales: | Shachar, Shlomit S, Deal, Allison M, Reeder-Hayes, Katherine E, Nyrop, Kirsten A, Mitin, Natalia, Anders, Carey K, Carey, Lisa A, Dees, E Claire, Jolly, Trevor A, Kimmick, Gretchen G, Karuturi, Meghan S, Reinbolt, Raquel E, Speca, JoEllen C, Muss, Hyman B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771421/ https://www.ncbi.nlm.nih.gov/pubmed/33409457 http://dx.doi.org/10.1093/jncics/pkaa082 |
Ejemplares similares
-
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022) -
Does walking during chemotherapy impact p16(INK4a)
levels in women with early breast cancer
por: Kammire, Maria S., et al.
Publicado: (2022) -
Physical Activity Intervention in Patients with Metastatic Breast Cancer During Active Treatment: Quality of Life and Function
por: Shachar, Shlomit Strulov, et al.
Publicado: (2022) -
p16 a biomarker of aging and tolerance for cancer therapy
por: Muss, Hyman B., et al.
Publicado: (2020) -
Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
por: Williams, Grant R., et al.
Publicado: (2017)